Clinical trial

SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

NCT07857616

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhasePHASE1

Study timeline

Study start (estimated)2026-09-01Date precision: month

Registry last updated2026-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Locally Advanced /Metastatic Solid Tumorsunresolved

Locally Advanced / Metastatic Solid Tumorsunresolved

Metastatic Solid Cancersunresolved

Non Small Cell Lung Cancercandidate · MONDO: non-small cell lung carcinoma

Lung Cancerverified · MONDO: lung cancer

Melanomaverified · MONDO: melanoma

Ovarianunresolved

NSCLCverified · MONDO: non-small cell lung carcinoma

Interventions

Sponsors & collaborators

SystImmune Inc.lead sponsor

Mapped research locations

HoustonTexas, United States1 DallasTexas, United States1 NashvilleTennessee, United States1 OrlandoFlorida, United States1 Oklahoma CityOklahoma, United States1 New HavenConnecticut, United States1 SarasotaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07857616 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.